43
Views
25
CrossRef citations to date
0
Altmetric
Research Article

In Vitro Study of the Anti-Leishmanial Activity of Biodegradable Nanoparticles

, , &
Pages 23-29 | Received 29 Aug 1994, Accepted 15 Nov 1994, Published online: 28 Sep 2008

References

  • Alving C. R. Delivery of liposome‐encapsulated drugs to macrophages. Pharmacol. Ther (1983); 22: 407–424
  • Babior B. M. Oxygen‐dependent microbial killing by phagocytes. N. Engl. J. Med (1978); 298: 659–662
  • Buchmuller Y., Mauel J. Studies on the mechanisms of macrophage activation; possible involvement of oxygen metabolites in the killing of Leishmania enriettii by activated mouse macrophage. J. Reticuloendothel. Soc (1981); 29: 181–186
  • Croft S. L. Recent developments in the chemotherapy of leishmaniasis. TIPS (1988); 9: 376–381
  • Croft S. L., Davidson R. N., Thornton E. A. Liposomal amphotericin B in the treatment of visceral leishmaniasis. J. Antimicrob. Chemother (1991); 28: 111–118, (Supp B)
  • Das N., Mahato S. B., Naskar K., Ghosh D. K., Basu M. K. Targeting of urea stibamine encapsulated in liposomes to reticuloendothelial system for the treatment of experimental leishmaniasis. Biochem. Med. Metab. Biol (1990); 43: 133–139
  • Fouarge M., Dewulf M., Couvreur P., Roland M., Vranckx H. Development of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis. J. Microencapsul (1989); 6(1)29–34
  • Gallis H. A., Drew R. H., Pickard W. W. Amphotericin B: 30 years of clinical experience. Rev. Infec. Dis (1991); 12(2)308–329
  • Gaspar R., Préat V., Opperdoes F., Roland M. Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production. Pharmaceut. Res (1992); 9(6)782–787
  • Grislain L., Couvreur P., Lenaerts V., Roland M., Deprez‐Decampeneere D., Trouet A., Speiser P. Pharmacokinetics and distribution of a biodegradable drug carrier. Int. J. Pharm (1983); 15: 335–345
  • Guiot P., Couvreur P. Quantitative study of the interaction between polybutylcyanoacrylate nanoparticles and mouse peritoneal macrophages in culture. J. Pharm. Belg (1983); 38(3)130–134
  • Guru P. Y., Agrawal A. K., Singha U. K., Singhal A., Gupta C. M. Drug targeting in Leishmania donovani infections using tufsin‐bearing liposomes as drug vehicles. FEBS Letters (1989); 245(1, 2)204–208
  • Haidaris C. G., Bonventre P. F. A role for oxygen‐dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages. J. Immunol (1982); 129(2)850–855
  • Hussein S., Curtis J., Griffiths D. W., Turk S. L. Study of DTH and resistance to Mycobacterium lepraemurium infection using a T‐cell line isolated from mice infected with Mycobacterium bovis BCG. Cell. Immunol (1987); 105: 423–427
  • Kern P. Leishmaniasis. Antibiot. Chemotherapy (1981); 30: 203–233
  • Nathan C. F. The role of oxidative metabolism in the cytotoxicity of activated macrophage after pharmacologic triggering. Immunobiology and immunotherapy of cancer, W. D. Terry, Y. Yamamura. Elsevier, New‐York (1979); 59
  • New R. R. C., Chance M. L., Heath S. Antileishmanial activity of amphotericin B and other antifungal agents entrapped in liposomes. J. Antimicrob. Chemother (1981); 8: 371–381
  • Ofek I., Sharon N. Lectinophagocytosis: a molecular mechanism of recognition between cell surface sugars and lectins in the phagocytosis bacteria. Infec. Immunity (1988); 56(3)539–547
  • Ogunkolade B. W., Vouldoukis I., Frommel D., Davoust B., Feuillette A. R., Monjour L. Immunization of dogs with leishmania infantum‐derived vaccine. Veterinary Parasitol (1988); 28: 33–41
  • Ruch W., Cooper P. H. W., Baggiolini M. Measurement of hydrogen peroxide release with homovanillic acid. J. Immunol. Method (1983); 63: 347–350
  • Russell D. G., Talamas‐Rohana P. Leishmania and the macrophage: a marriage of inconvenience. Immunol. Today (1989); 10(10)328–332
  • Simpson D. W., Roth R., Loose L. D. A rapid, inexpensive and easily quantified assay for phagocytosis and microbicidal activity of macrophages and neutrophiles. J. Immunol. Methods (1979); 29: 221–226
  • Spenlehauer G., Vert M., Benoît J. P., Chabot F., Veillard M. Biodegradable cisplatin microspheres prepared by the solvent evaporation method: morphology and release characteristics. J. Control. Release (1988); 7: 217–229
  • Tabata Y., Ikada Y. Macrophage phagocytosis of biodegradable microspheres composed of 1‐lactic acid/glycolic acid homo‐ and copolymers. J. Biom. Mater. Res (1988); 22: 837–858, The Merck Index, tenth edition (1983). Windholz M., Budavari, S., Blumetty, R. F., Otterbein, E.S., (eds). (Rahway, N.J.: Merck and Co) pp 1463
  • Therin M., Christel P., Li S., Garreau H., Vert M. In vivo degradation of massive poly(α‐hydroxy acids): validation of in vitro findings. Biomaterials (1992); 13(9)594–600
  • Vouldoukis I., Alfred C., Monjour L., Mazier D., Branicourt O., Ploton I., Tselentis Y., Nzuzi K. K., Gentilini M. Etude de systèmes de culture pour la production des formes promastigotes et amastigotes des leishmanies. Application au diagnostic sérologique et aux essais thérapeutiques. Ann. Parasitol. Hum. Comp (1986); 61(2)147–154
  • Wilson M. E., Pearson R. D. Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism. J. Immunol (1986); 136(12)4681–1688

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.